Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Planning and Dissemination Grant - Institute Community Support

University of Toronto

$20,000.00

Towards strengthening implementation of sex and gender-based analyses in clinical trials among Canadian researchers: engaging diverse researchers to understand perceived barriers and guide renewed avenues of support

FY 2023-24

Summary
While it is widely accepted that all Canadians have an equal right to healthcare, limited inclusion of sex and gender in health research reinforces inequity. The risk of heart disease, the leading cause of death in Canada and globally, is greater in women. Other risk factors like smoking, diabetes, and obesity, are also higher in women and there are sex differences in the response to heart disease treatments. Risk also differs by gender-related social and cultural factors. Thus, there is an urgent need to support doing sex and gender analyses in health research for heart disease, especially in clinical trials as they have the greatest impact on guidelines and policies. Though government agencies are committed to supporting sex and gender analyses, the use in health research is limited. To understand the barriers Canadian trialists face in including sex and gender analyses, 3 meetings will be held across Canada (June 2024 to May 2025). Canadian trialists of diverse backgrounds will join these meetings alongside experts in sex and gender science and representatives from national training programs. Discussions will focus on identifying barriers to doing sex and gender analyses in trials and needs, like tools to support training. This study will support creation of an advisory committee of diverse Canadian trialists and strengthen partnerships with national training organizations and decision makers. Together, these partners will meet 6 times to develop future studies to further understand diverse needs of trialists across Canada, the co-design of tools to support training, and updates and/or new training platforms. This work will support Canadian trialists to meet the urgent call to provide the best evidence showing differences by sex and gender. This action will allow for more informed guidelines which meet the unique needs of all Canadians, to reduce the rising rates of heart disease, especially those at greatest risk.
Program
Planning and Dissemination Grant - Institute Community Support
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
499844
Name
Chiavaroli Laura
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Clinical
Prcname2
Planning and Dissemination Grants
Projecttitle
Towards strengthening implementation of sex and gender-based analyses in clinical trials among Canadian researchers: engaging diverse researchers to understand perceived barriers and guide renewed avenues of support
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Toronto
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Advancing Health Equity; Barriers; Canadian Researchers; Human Clinical Trials; Sex And Gender-Based Analyses
Abstract
While it is widely accepted that all Canadians have an equal right to healthcare, limited inclusion of sex and gender in health research reinforces inequity. The risk of heart disease, the leading cause of death in Canada and globally, is greater in women. Other risk factors like smoking, diabetes, and obesity, are also higher in women and there are sex differences in the response to heart disease treatments. Risk also differs by gender-related social and cultural factors. Thus, there is an urgent need to support doing sex and gender analyses in health research for heart disease, especially in clinical trials as they have the greatest impact on guidelines and policies. Though government agencies are committed to supporting sex and gender analyses, the use in health research is limited. To understand the barriers Canadian trialists face in including sex and gender analyses, 3 meetings will be held across Canada (June 2024 to May 2025). Canadian trialists of diverse backgrounds will join these meetings alongside experts in sex and gender science and representatives from national training programs. Discussions will focus on identifying barriers to doing sex and gender analyses in trials and needs, like tools to support training. This study will support creation of an advisory committee of diverse Canadian trialists and strengthen partnerships with national training organizations and decision makers. Together, these partners will meet 6 times to develop future studies to further understand diverse needs of trialists across Canada, the co-design of tools to support training, and updates and/or new training platforms. This work will support Canadian trialists to meet the urgent call to provide the best evidence showing differences by sex and gender. This action will allow for more informed guidelines which meet the unique needs of all Canadians, to reduce the rising rates of heart disease, especially those at greatest risk.
Competitiondate
202402
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chiavaroli, Laura
Approvedterm
1 an 0 mois
Cihrcontribution2
IGH~ $20,000~ $0~